Journal article
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
Frontiers in bioengineering and biotechnology, 2021. Huang Y, He Y, Makarcyzk MJ and 1 others.
Study type
Journal article
Subjects
Not classified in PubMed MeSH
Journal
Frontiers in bioengineering and biotechnology
Published
2021
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Other papers on FOXO4-DRI
Journal article · 2025
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
Journal article · 2017Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page